Abstract
New tetrazole-containing derivatives of 2,4-diamino-1,3,5-triazine were synthesized. The cytotoxic activity of the obtained compounds against Huh-7 and HeLa tumor cell lines was studied by the MTT test. The most significant antitumor activity was shown by 1,3,5-triazines containing a 5-phenyltetrazol-2-ylacetohydrazide fragment. The resulting compounds showed practically no cytotoxic effect on non-tumor cells of the human embryonic kidney line HEK293.
Similar content being viewed by others
REFERENCES
Singh, S., Mandal, M.K., Masih, A., Saha, A., Ghosh, S.K., Bhat, H.R., and Singh, U.P., Arch. Pharm., 2021, vol. 354, no. 6, article no. 2000363. https://doi.org/10.1002/ardp.202000363
Singla, P., Luxami, V., and Paul, K., Eur. J. Med. Chem., 2015, vol. 102, p. 39. https://doi.org/10.1016/j.ejmech.2015.07.037
Cascioferro, S., Parrino, B., Spanò, V., Carbone, A., Montalbano, A., Barraja, P., Diana, P., and Cirrincione, G., Eur. J. Med. Chem., 2017, vol. 142, p. 523. https://doi.org/10.1016/j.ejmech.2017.09.035
Shah, D.R., Modh, R.P., and Chikhalia, K.H., Future Med. Chem., 2014, vol. 6., no. 4, p. 463. https://doi.org/10.4155/fmc.13.212
Sonawane, R.P., Sikervar, V., and Sasmal, S., Compr. Heterocycl. Chem., 2022, vol. 9, p. 181. https://doi.org/10.1016/B978-0-12-818655-8.00018-4
Maliszewski, D. and Drozdowska, D., Pharmaceuticals, 2022, vol. 15, no. 2, p. 221. https://doi.org/10.3390/ph15020221
Hiebel, M.-A. and Suzenet, F., Progr. Heterocycl. Chem., 2021, vol. 33, p. 441. https://doi.org/10.1016/B978-0-323-98410-2.00014-X
Hu, J., Zhang, Y., Tang, N., Lu, Y., Guo, P., and Huang, Z., Bioorg. Med. Chem., 2021, vol. 32, article no. 115997. https://doi.org/10.1016/j.bmc.2021.115997
Pratt, W.B. and Ruddon, R.W., The Anticancer Drugs, New York: Oxford University Press, 1979.
Krętowski, R., Drozdowska, D., Kolesińska, B., Kamiński, Z., Frączyk, J., and Cechowska-Pasko, M., Invest. New Drugs, 2019, vol. 37, no. 5, p. 984. https://doi.org/10.1007/s10637-018-0712-8
Rageot, D., Bohnacker, T., Melone, A., Langlois, J.-B., Borsari, C., Hillmann, P., Sele, A.M., Beaufils, F., Zvelebil, M., Hebeisen, P., Löscher, W., Burke, J., Doriano Fabbro, D., and Wymann, M.P., J. Med. Chem., 2018, vol. 61, no. 22, p. 10084. https://doi.org/10.1021/acs.jmedchem.8b01262
Beaufils, F., Cmiljanovic, N., Cmiljanovic, V., Bohnacker, T., Melone, A., Marone, R., Jackson, E., Zhang, X., Sele, A., Borsari, C., Mestan, J., Hebeisen, P., Hillmann, P., Giese, B., Zvelebil, M., Fabbro, D., Williams, R.L., Rageot, D., and Wymann, M.P., J. Med. Chem., 2017, vol. 60, no. 17, p. 7524. https://doi.org/10.1021/acs.jmedchem.7b00930
Prasher, P., Sharma, M., Aljabali, A.A.A., Gupta, G., Negi, P., Kapoor, D.N., Singh, I., Zacconi, F.C., Pinto, T.J.A., da Silva, M.W., Bakshi, H.A., Chellappan, D.K., Tambuwala, M.M., and Dua, K., Drug Dev. Res., 2020, vol. 81, no. 7, p. 837. https://doi.org/10.1002/ddr.21704
Guo, H. and Diao, Q.-P., Curr. Top. Med. Chem., 2020, vol. 20, no. 16, p. 1481. https://doi.org/10.2174/1568026620666200310122741
Popova, E.A., Trifonov, R.E., and Ostrovskii, V.A., Russ. Chem. Rev., 2019, vol. 88, p. 644. https://doi.org/10.1070/RCR4864
Ostrovskii, V.A., Trifonov, R.E., and Popova, E.A., Russ. Chem. Bull., 2012, vol. 61, no. 4, p. 768. https://doi.org/10.1007/s11172-012-0108-4
Ostrovskii, V.A., Popova, E.A., and Trifonov, R.E., Compr. Heterocycl. Chem., 2022, p. 182. https://doi.org/10.1016/B978-0-12-818655-8.00131-1
Herr, R.J., Bioorg. Med. Chem., 2002, vol. 10, no. 11, p. 3379. https://doi.org/10.1016/S0968-0896(02)00239-0
Popova, E.A., Protas, A.V., and Trifonov, R.E., AntiCancer Agents Med. Chem., 2017, vol. 17, no. 14, p. 1856. https://doi.org/10.2174/1871520617666170327143148
Ostrovskii, V.A., Popova, E.A., and Trifonov, R.E., Adv. Heterocycl. Chem., 2017, vol. 123, p. 1. https://doi.org/10.1016/bs.aihch.2016.12.003
Popova, E.A. and Trifonov, R.E., Russ. Chem. Rev., 2015, vol. 84, no. 9, p. 891. https://doi.org/10.1070/RCR4527
Mikolaichuk, O.V., Sharoyko, V.V., Popova, E.A., Protas, A.V., Fonin, A.V., Anufrikov, Y.A., Malkova, A.M., Shmaneva, N.T., Ostrovskii, V.A., and Semenov, K.N., Russ. Chem. Bull., 2022, vol. 71, no. 5, p. 1050. https://doi.org/10.1007/s11172-022-3507-1
Blotny, G., Tetrahedron, 2006, vol. 62, no. 41, p. 9507. https://doi.org/10.1016/j.tet.2006.07.039
Ostrovskii, V.А., Danagulyan, G.G., Nesterova, O.M., Pavlyukova, Y.N., Tolstyakov, V.V., Zarubina, O.S., Slepukhin, P.А., Esaulkova, Y.L., Muryleva, A.А., Zarubaev, V.V., and Trifonov, R.E., Chem. Heterocycl. Compd., 2021, vol. 57, no. 4, p. 448. https://doi.org/10.1007/s10593-021-02922-6
Putis, S.M., Zubarev, V.Y., Poplavskii, V.S., and Ostrovskii, V.A., Chem. Heterocycl. Compd., 2001, no. 6, p. 759. https://doi.org/10.1023/A:1011909127876
Vereshchagin, L.I., Verkhozina, O.N., Pokatilov, F.A., Proidakov, A.G., and Kizhnyaev, V.N., Chem. Heterocycl. Compd., 2010, vol. 46, no. 2, p. 206. https://doi.org/10.1007/s10593-010-0493-2
Mikolaichuk, O.V., Popova, E.A., Protas, A.V., Rakipov, I.T., Nerukh, D.A., Petrov, A.V., Charykov, N.A., Ageev, S.V., Tochilnikov, G.V., Zmitrichenko, I.G., Stukov, A.N., Semenov, K.N., and Sharoyko, V.V., J. Mol. Liq., 2022, vol. 356, article no. 119043. https://doi.org/10.1016/j.molliq.2022.119043
ACKNOWLEDGMENTS
The authors are grateful to the Resource Centers of St. Petersburg State University “Magnetic Resonance Research Center,” “Chemical Analysis and Materials Research Center,” and “Center for Thermogravimetric and Calorimetric Research.”
Funding
This work was financially supported by the Ministry of Health of the Russian Federation (government task on the topic “Creation and evaluation of the antitumor activity of conjugates of non-annulated 1,3,5-triazinyl-tetrazoles with targeted delivery molecules to microenvironment tumor cells targets”).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Mikolaichuk, O.V., Protas, A.V., Popova, E.A. et al. Synthesis and In vitro Study of Cytotoxic Activity of New Tetrazole-Containing 2,4-Diamino-1,3,5-triazine Derivatives. Russ J Gen Chem 92, 1621–1628 (2022). https://doi.org/10.1134/S1070363222090055
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070363222090055